SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-013264
Filing Date
2019-03-07
Accepted
2019-03-07 08:00:59
Documents
3
Period of Report
2019-03-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-4982_38k.htm 8-K 22103
2 EX-99.1 a19-4982_3ex99d1.htm EX-99.1 99303
3 GRAPHIC g49823mm01i001.jpg GRAPHIC 2647
  Complete submission text file 0001104659-19-013264.txt   126432
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33451 | Film No.: 19664360
SIC: 2834 Pharmaceutical Preparations